BE: Please report adverse events to the Belgian Centre for Pharmacovigilance for medicines for Human use of the Federal Agency for Medicines and Health Products via adr@afmps.be or via www.notifieruneffetindesirable.be or to GlaxoSmithKline Pharmaceuticals s.a./n.v. via be.medinfo@gsk.com.

LUX: Please report adverse events to the Centre Régional de Pharmacovigilance de Nancy or Division de la pharmacie et des médicaments de la Direction de la santé via www.guichet.lu/pharmacovigilance or to GlaxoSmithKline Pharmaceuticals s.a./n.v. via be.medinfo@gsk.com.